What initial dose of vasopressin should be started in an adult with refractory shock?

Vasopressin Starting Dose in Refractory Shock

Start vasopressin at 0.03 units/minute (not 0.04 units/minute) when adding it to norepinephrine in adults with refractory shock.

Guideline-Based Recommendation

The Surviving Sepsis Campaign 2016 guidelines explicitly recommend vasopressin at 0.03 units/minute as an adjunctive vasopressor to norepinephrine in septic shock 1, 2, 1. This dose can be added with the intent of either raising mean arterial pressure to target (≥65 mmHg) or decreasing norepinephrine requirements 1.

Critical caveats:

• Vasopressin should NOT be used as the single initial vasopressor 1, 2
• Doses higher than 0.03-0.04 units/minute should be reserved for salvage therapy only (when other vasopressors have failed to achieve adequate MAP) 1
• Norepinephrine remains the first-choice vasopressor; vasopressin is added when norepinephrine alone is insufficient 1

FDA-Approved Dosing

The FDA label for vasopressin provides context-specific dosing 3:

• Septic shock: 0.01 to 0.07 units/minute
• Post-cardiotomy shock: 0.03 to 0.1 units/minute

However, the FDA label confirms that the standard therapeutic range aligns with guideline recommendations, with 0.03 units/minute being the established dose 3.

Evidence Supporting 0.03 vs 0.04 Units/Minute

While 0.04 units/minute is commonly used in clinical practice, recent evidence shows no advantage over 0.03 units/minute. A 2022 multicenter study of 1,536 patients with septic shock found no difference in hemodynamic response between initial doses of 0.03 and 0.04 units/minute (50.0% vs 53.1% response rate, adjusted RR 1.06 [95% CI 0.94-1.20]) 4. This supports using the lower guideline-recommended dose of 0.03 units/minute.

Practical Implementation Algorithm

When to add vasopressin:

1. Patient has adequate fluid resuscitation
2. Norepinephrine is already running (typically when doses exceed 0.25-0.5 µg/kg/min, though guidelines don't specify an exact threshold)
3. MAP remains <65 mmHg despite norepinephrine

How to start:

• Dilute the 20 units/mL vial with normal saline or D5W to either 0.1 units/mL or 1 unit/mL 3
• Start at 0.03 units/minute as a fixed-dose infusion (do not titrate initially)
• Discard unused diluted solution after 18 hours at room temperature or 24 hours refrigerated 3

Expected response:

• Pressor effect peaks within 15 minutes 3
• Steady-state plasma concentrations achieved after 30 minutes 3
• Effect fades within 20 minutes after stopping 3

Important Safety Considerations

Monitoring requirements:

• Place an arterial catheter as soon as practical 1
• Monitor for decreased cardiac output and bradycardia 3
• Watch for ischemic complications (coronary, mesenteric, skin, digital) 3
• Monitor serum sodium (vasopressin can cause hyponatremia) 3

Drug interactions:

• Indomethacin may prolong vasopressin's effects 3
• Ganglionic blockers may increase pressor response 3
• Pressor effects with catecholamines are additive 3

Mortality and Outcome Data

The landmark VASST trial (778 patients) showed no overall mortality difference between low-dose vasopressin (0.01-0.03 units/minute) and norepinephrine (28-day mortality 35.4% vs 39.3%, p=0.26) 5. However, in less severe septic shock, vasopressin was associated with lower 28-day mortality (26.5% vs 35.7%, p=0.05) 5.

The primary benefit of vasopressin is norepinephrine-sparing (reducing catecholamine requirements), which may theoretically reduce catecholamine-related adverse effects, though definitive outcome benefits remain unproven 6.

Common Pitfall to Avoid

Do not start at 0.04 units/minute simply because it's commonly used in practice. The evidence shows no benefit over 0.03 units/minute 4, and guidelines explicitly recommend 0.03 units/minute 1, 2. Starting at the lower dose provides adequate hemodynamic support while minimizing potential adverse effects, with the option to increase to 0.04 units/minute for salvage therapy if needed.